Viatris Inc (VTRS)
11.60
-0.03
(-0.26%)
USD |
NASDAQ |
May 02, 16:00
11.60
0.00 (0.00%)
After-Hours: 18:30
Viatris Enterprise Value: 30.75B for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 01, 2024 | 30.75B |
April 30, 2024 | 30.68B |
April 29, 2024 | 30.93B |
April 26, 2024 | 30.68B |
April 25, 2024 | 30.56B |
April 24, 2024 | 30.65B |
April 23, 2024 | 30.43B |
April 22, 2024 | 30.30B |
April 19, 2024 | 30.30B |
April 18, 2024 | 30.14B |
April 17, 2024 | 30.12B |
April 16, 2024 | 30.14B |
April 15, 2024 | 30.38B |
April 12, 2024 | 30.39B |
April 11, 2024 | 30.68B |
April 10, 2024 | 30.84B |
April 09, 2024 | 30.98B |
April 08, 2024 | 30.89B |
April 05, 2024 | 30.95B |
April 04, 2024 | 30.90B |
April 03, 2024 | 31.21B |
April 02, 2024 | 31.12B |
April 01, 2024 | 31.12B |
March 28, 2024 | 31.12B |
March 27, 2024 | 30.99B |
Date | Value |
---|---|
March 26, 2024 | 30.71B |
March 25, 2024 | 30.99B |
March 22, 2024 | 31.00B |
March 21, 2024 | 31.20B |
March 20, 2024 | 31.05B |
March 19, 2024 | 31.03B |
March 18, 2024 | 30.90B |
March 15, 2024 | 31.12B |
March 14, 2024 | 30.98B |
March 13, 2024 | 31.25B |
March 12, 2024 | 31.26B |
March 11, 2024 | 31.15B |
March 08, 2024 | 31.50B |
March 07, 2024 | 31.58B |
March 06, 2024 | 31.43B |
March 05, 2024 | 31.52B |
March 04, 2024 | 31.62B |
March 01, 2024 | 31.89B |
February 29, 2024 | 31.63B |
February 28, 2024 | 31.53B |
February 27, 2024 | 32.65B |
February 26, 2024 | 32.89B |
February 23, 2024 | 33.01B |
February 22, 2024 | 32.80B |
February 21, 2024 | 32.86B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
18.93B
Minimum
Mar 12 2020
47.41B
Maximum
Dec 31 2020
30.51B
Average
30.84B
Median
Apr 10 2024
Enterprise Value Benchmarks
Pfizer Inc | 211.91B |
Johnson & Johnson | 371.26B |
Masimo Corp | 7.831B |
QuidelOrtho Corp | 4.898B |
Evolus Inc | 847.45M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -765.60M |
Revenue (Quarterly) | 3.837B |
Total Expenses (Quarterly) | 4.049B |
EPS Diluted (Quarterly) | -0.64 |
Gross Profit Margin (Quarterly) | 41.60% |
Profit Margin (Quarterly) | -19.95% |
Earnings Yield | 0.34% |
Operating Earnings Yield | 7.02% |
Normalized Earnings Yield | 1.741 |